Skip to content

Very Low Dose Caudal Morphine for Postoperative Pain Management

The Use of Very Low Dose Caudal Morphine for Postoperative Pain Management in Out Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00938821
Enrollment
33
Registered
2009-07-14
Start date
2010-01-31
Completion date
2012-12-11
Last updated
2017-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caudal Anesthesia

Brief summary

This is a chart review. The aim of this study is to investigate the effectiveness and side effects of very low dose morphine administered caudally to children that went to surgical procedures that used caudal anesthesia. The study compares caudal block with Bupivacaine (1 ml kg\_1 of bupivacaine 0.25% and saline 0.02 ml kg\_10) with very low dose morphine (a mix of 1 ml kg\_-1 of ropivacaine 0.2% and preservative-free morphine: 10 µg kg-1).

Detailed description

Caudal anesthesia is the most common technique of epidural anesthesia in children. Caudal anesthesia is recommended for most surgical procedures of the lower part of the body, including herniorrhaphies; operations on the urinary tract, anus, and rectum; and orthopedic procedures on the pelvic girdle and lower extremities. Many anesthetic agents have been used for caudal anesthesia in pediatric patients, with lidocaine and Bupivacaine being most common. The major problems associated with this technique are the limited duration of analgesia and unwanted motor blockade. Addition of medications that prolong analgesia after a single shot caudal block has been investigated. Several authors have mentioned a special interest in using an opioid like morphine in caudal block for postoperative analgesia. When low dose morphine is used, the side effects are lower than when higher dose of morphine are used. A larger and definitive study is needed to compare very low dose morphine via caudal administration and caudal block without Opioid with regard to duration of analgesia and frequency of side effects. We plan to conduct a chart review in our center on pediatric patients that went to urological, orthopedic, and general surgery procedures for which caudal block were given and compare the effectiveness and side effects of very low dose morphine and caudal block without Opioid.

Interventions

PROCEDURECaudal block

Chart review of patients that received very low dose morphine administered caudally (M) and plain caudal block with Ropivacaine or Marcaine (B)from October 2008 to October 2009.

Sponsors

University of Oklahoma
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Months to 10 Years
Healthy volunteers
No

Inclusion criteria

* The subject did have elective Urological procedures such us circumcision, orchidopexy and inguinal hernia repair, orthopedic and general surgery procedures for which caudal block are usually administered for pain management.

Exclusion criteria

* Subjects with non elective or emergency surgery (must have the surgery no matter what). * Subjects with surgical procedures that are not planned to be conducted with the use of general anesthesia. Subjects that are not allowed to receive the anesthesia agents indicated per protocol and general anesthesia. * American Society of Anesthesiologists, Physical Status classification greater than 2 (uncontrolled systemic disease or more than one systemic disease). * Patients with a history of chronic pain conditions. * Infection around the sacral hiatus. * Coagulopathy. * Anatomic abnormalities. * Patient with mentally retardation. * Patient with history of attention deficit and/or behavioral problems.

Design outcomes

Primary

MeasureTime frame
The study's primary research question, which relates to between-group differences is duration of analgesia.1 year 5 months

Secondary

MeasureTime frame
Between-group differences in the proportion of patients clinically significant side effects will be assessed.1 year 5 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026